Observational Safety Study of Clottafact(®) Fibrinogen Concentrate: Real-World Data in Mexico

BACKGROUND AND OBJECTIVE: The use of fibrinogen concentrate to treat or prevent major bleeding with regard to potential adverse reactions has not been free of controversy. Our objective was to perform a post-authorization safety study to describe the use of Clottafact(®) (LFB Biomedicaments) fibrino...

Descripción completa

Detalles Bibliográficos
Autores principales: Colin-Bracamontes, Ignacio, Pérez-Calatayud, Ángel Augusto, Carrillo-Esper, Raúl, Rodríguez-Ayala, Ernesto, Padilla-Molina, Misael, Posadas-Nava, Alejandro, Olvera-Vázquez, Susana, Hernández-Salgado, Lidia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181537/
https://www.ncbi.nlm.nih.gov/pubmed/32215860
http://dx.doi.org/10.1007/s40261-020-00906-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181537/
https://www.ncbi.nlm.nih.gov/pubmed/32215860
http://dx.doi.org/10.1007/s40261-020-00906-6

Ejemplares similares